skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
09/19/2000
Application #:
08826050
Filing Dt:
03/28/1997
Inventors:
SHAU-KU HUANG, MARSHA WILLS-KARP, XIU-MIN LI, ANDREA KEANE-MYERS
Title:
THERAPY FOR ALLERGIC DISEASES
Assignment: 1
Reel/Frame:
008716/0343Recorded: 09/19/1997Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
07/17/1997
Exec Dt:
07/30/1997
Exec Dt:
07/22/1997
Exec Dt:
08/27/1997
Assignee:
720 RUTLAND AVENUE
BALTIMORE, MARYLAND 21205
Correspondent:
BANNER & WITCOTT, LTD.
SARAH A. KAGAN
1001 G STREET, N.W.
SUITE 1100
WASHINGTON, D.C. 20004-4597
Assignment: 2
Reel/Frame:
010339/0715Recorded: 09/19/1997Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
07/17/1997
Exec Dt:
07/30/1997
Exec Dt:
07/22/1997
Exec Dt:
08/27/1997
Assignee:
720 RUTLAND AVENUE
BALTIMORE, MARYLAND 21205
Correspondent:
BANNER & WITCOFF, LTD.
SARAH A. KAGAN
1001 G STREET, N.W., SUITE 1100
WASHINGTON, DC 20001-4597
Assignment: 3
Reel/Frame:
022093/0958Recorded: 01/12/2009Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/02/1998
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/02/2024 12:20 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT